Brief: Oragenics Provides Q1 2025 Shareholder Update On Strategic And Financial Progress
27/03/2025 12:35
March 27 (Reuters) - Oragenics Inc OGEN.A: ORAGENICS, INC. PROVIDES Q1 2025 SHAREHOLDER UPDATE ON STRATEGIC AND FINANCIAL PROGRESS Source text: ID:nGNX43Xhlk Further company coverage: OGEN.A ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oragenics
See all newsBrief: Oragenics Reports Continued Clinical Progress, Provides Regulatory And NYSE American Listing Update
Brief: Oragenics Signs Letter Of Intent To License Cardiodialysis™ Technology From Sigyn Therapeutics To Target Tbi-Induced Systemic Inflammation
Brief: Oragenics Inc - Signs Letter Of Intent To License Cardiodialysis From Sigyn Therapeutics - SEC Filing
Brief: Oragenics Activates Second Site In Phase Iia Clinical Trial Of Onp-002 For Concussion And Mild Traumatic Brain Injury.
Brief: Oragenics Enters Settlement Agreement With Ladenburg Thalmann - Sec Filing